Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

February 28, 2011

Study Completion Date

December 31, 2011

Conditions
Japanese Encephalitis
Interventions
BIOLOGICAL

ChimeriVax™-JE

One dose of 4.0 log10 PFU is given in a volume of 1 ml for children aged \> 3 years and 0.5 ml to children and infants aged \< 3 years administered subcutaneously

BIOLOGICAL

Japanese Encephalitis Inactivated Mouse Brain Vaccine

Two doses of 1 ml reconstituted JE-MBDV is given to subjects aged \> 3 years and 0.5 ml is given to children and infants aged \< 3 years administered subcutaneously

Trial Locations (3)

110002

Maulana Azad Medical College, New Delhi

302016

Dr Atul's Child Hospital, Jaipur

390001

Government Medical College, Baroda

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY